The startup develops a non-invasive medical device that utilizes transcutaneous electrical nerve stimulation (TENS) to target the posterior tibial nerve, providing relief for patients suffering from overactive bladder syndrome. This device offers a practical alternative to traditional treatments, enhancing patient quality of life in the French market.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Overactive bladder syndrome, characterized by urinary urgency, frequency, and nocturia, significantly diminishes patients' quality of life. Traditional treatments often involve medication with potential side effects or invasive procedures, creating a need for practical, non-pharmacological alternatives.
Solution
Tensi+ offers a non-invasive, non-drug based treatment for overactive bladder by utilizing transcutaneous electrical nerve stimulation (TENS) to stimulate the posterior tibial nerve. The Tensi+ device is easily applied to the inner ankle and delivers a 20-minute daily TENS therapy, reducing the symptoms of idiopathic or neurologic overactive bladder. Clinical studies have demonstrated the effectiveness of TENS in reducing urinary urgency, frequency, nocturia, and urge incontinence. The device is designed for autonomous use, allowing patients to continue their daily activities during treatment.
Target Audience
The primary audience includes individuals experiencing symptoms of overactive bladder, such as urinary urgency, frequent urination, nighttime urination, and urge incontinence, as well as urologists, gynecologists, rehabilitation physicians, and general practitioners seeking a non-pharmacological treatment option for their patients.
Features
- Non-invasive TENS therapy delivered via a compact, wearable device
- Integrated conductive electrodes positioned for targeted stimulation of the posterior tibial nerve
- User-friendly design for self-administration at home or on the go
- Pre-set 20-minute treatment duration with automatic shut-off
- Intensity adjustment with LED indicators for personalized comfort
- Rechargeable battery with included USB charging cable
- Device is marked CE (class IIa) compliant with the regulation 2017/745 relating to medical devices